All Stories

  1. Use of and attitudes to the role of medication for acute whiplash injury: A preliminary survey of emergency department doctors
  2. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities
  3. N-of-1 trials in the clinical care of patients in developing countries: a systematic review
  4. Barriers for conducting clinical trials in developing countries- a systematic review
  5. Pregabalin versus placebo in targeting pro-nociceptive mechanisms to prevent chronic pain after whiplash injury in at-risk individuals – a feasibility study for a randomised controlled trial
  6. Sun protective behaviors at an outdoor entertainment event in Australia
  7. Management of Whiplash Associated Disorders in Australian general practice
  8. A series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial
  9. A series of n-of-1 trials of stimulants in brain injured children
  10. Paracetamol for pain in advanced cancer patients on opioids - does it help?
  11. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement†
  12. Improving the reporting of N-of-1 trials
  13. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration
  14. N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis
  15. To meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHD
  16. Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial
  17. Do N-of-1 Trials Need IRB Review?
  18. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  19. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  20. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  21. The Single-Case Reporting guideline In BEhavioural interventions (SCRIBE) 2016 statement
  22. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 statement
  23. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  24. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  25. Sun protection policies of Australian primary schools in a region of high sun exposure
  26. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
  27. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  28. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial
  29. Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study
  30. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
  31. CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration
  32. The Essential Guide to N-of-1 Trials in Health
  33. Introduction to The essential guide to N-of-1 trials in health
  34. An overview of the potential future applications of N-of-1 Trials
  35. What are N-of-1 Trials?
  36. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury – a pilot study
  37. Don’t burn the baby: Advice from Australian nurses recommending therapeutic sun exposure during infancy
  38. Identifying individual responders to pilocarpine
  39. Psychostimulants to reduce fatigue in advanced cancer patients
  40. Central nervous system stimulants for secondary ADHD after paediatric traumatic brain injury
  41. Exploring melatonin prescribing among customers of compounding pharmacies in Australia
  42. An Observational Study of Sun-Protective Behaviour at an Outdoor Spectator Sporting Event in a Region of High Sun Exposure
  43. Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care
  44. Pilot Study To Determine the Optimal Dose of Methylphenidate for an n-of-1 Trial for Fatigue in Patients with Cancer
  45. Using N-of-1 Trials to Improve Patient Management and Save Costs
  46. Stakeholders' views on the routine use of n-of-1 trials to improve clinical care and to make resource allocation decisions for drug use
  47. Prioritising drugs for single patient (n-of-1) trials in palliative care
  48. N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain
  49. Are N-of-1 Trials an Economically Viable Option to Improve Access to Selected High Cost Medications? The Australian Experience
  50. Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder
  51. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials
  52. An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder
  53. The Role of Paracetamol in Chronic Pain: An Evidence-Based Approach
  54. Do Individualized Medication Effectiveness Tests (N-of-1 Trials) Change Clinical Decisions About Which Drugs to Use for Osteoarthritis and Chronic Pain?
  55. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials
  56. Bias influencing maternal reports of child behaviour and emotional state
  57. Mothers' Mental Illness and Child Behavior Problems: Cause-Effect Association or Observation Bias?